-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Sumitomo Pharma America Announces Enzomenib (Dsp-5336) Receives FDA Orphan Drug Designation For Treatment Of Acute Lymphoblastic Leukemia

Reuters·07/30/2026 12:08:01

Please log in to view news